TUESDAY, SEPTEMBER 27, 2016

London School of Hygiene & Tropical Medicine


London School of Hygiene & Tropical Medicine News

More than 2 million people have HIV and hepatitis C co-infections

A recent study from the University of Bristol and the London School of Hygiene & Tropical Medicine found that approximately 2.3 million people around the world have co-infections of human immunodeficiency virus (HIV) and hepatitis C (HCV). Read More »

Some London boroughs face significantly high TB rates

A recent report issued from the London Assembly shows there are specific boroughs within London that have significantly high tuberculosis rates, despite the nation’s efforts to eliminate the disease. Read More »

HIV treatments at work save company money

Companies that offer antiretroviral therapy programs for people with HIV within the workplace can save themselves costs through reducing absenteeism, staff turnover and healthcare costs. Read More »

Researchers find new methods to eliminate malaria parasite

Scientists from the Toxicology Unit of the Medical Research Council (MRC) at the University of Leicester and the London School of Hygiene & Tropical Medicine recently discovered a new method to eliminate malaria parasites. Read More »

Fake malaria drugs less common than originally estimated

Experts recently analyzed the quality of anti-malarial drugs in Tanzania and Cambodia, finding no evidence of fake medicines in those regions. Read More »

New genetic mutation could indicate drug-resistant malaria in Africa

Researchers from the London School of Hygiene and Tropical Medicine have discovered a new genetic mutation in Plasmodium falciparum, the parasite that causes malaria, which may mean the beginning of drug-resistant malaria in Africa. Read More »

KalaCORE launched to eliminate visceral leishmaniasis

Health professionals have developed a new partnership program to eliminate visceral leishmaniasis, a deadly illness in Asia and several African countries. Read More »

Ebola vaccine clinical trial receives funding

Thanks to more than $249 million US funds financing the team’s research, the EU Innovative Medicines Initiative (IMI) recently announced that the London School of Hygiene & Tropical Medicine has started to plan clinical trials for an Ebola vaccine. Read More »

Blood from Ebola survivors examined for potential treatment options

An international research consortium next month will begin examining the use of antibodies from the blood of Ebola survivors to help infected Ebola patients ward off the disease. Read More »

Monkeybar project uses drones to track malaria in Asia

The London School of Hygiene & Tropical Medicine believes drones can help with cutting costs when it comes to ecological research. Read More »